CTRI/2024/06/069627尚未招募4 期
ong term immunogenicity of a marketed quadrivalent influenza vaccine (FluQuadriTM) administered in participants 60 years of age and older- An extension study [of EC/GOVT-02/2020] - NI
Dr Nithya Gogtay0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1 The participants recruited in the INCENTIVE QIV1 study.
- •2 Participants from INCENTIVE QIV1 [original study] now willing to participate and provide a written informed consent
排除标准
- •1 History of any influenza vaccine administration during the past 6 months prior to the present study.
- •2 Current or previous, laboratory confirmed case of influenza during the past 6 months, based on anamnesis at screening visit.
- •3 Household contact with and/or intimate exposure to an individual with any laboratory confirmed influenza infection within 90 days prior to vaccination.
- •4 Have any bleeding disorder which is considered as a contraindication to blood draw according to the opinion of the investigator.
- •5 Any other condition that in the opinion of the investigator would jeopardize the safety or rights of the volunteer participating in the study or make it unlikely that the participant could complete the protocol
研究者
相似试验
进行中（未招募）
1 期
Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or Concomitantly with Two Other Vaccines in Healthy AdolescentsMeningococcal infectionMedDRA version: 20.0Level: PTClassification code 10027274Term: Meningococcal infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2020-001665-37-ITSANOFI PASTEUR464
进行中（未招募）
1 期
Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or Concomitantly with Two Other Vaccines in Healthy AdolescentsMeningococcal infectionMedDRA version: 20.0Level: PTClassification code 10027274Term: Meningococcal infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2020-001665-37-HUSanofi Pasteur464
进行中（未招募）
1 期
Efficacy and Immunogenicity Study of Quadrivalent Influenza Vaccine Administered via the Intramuscular Route in Healthy Children Aged 6 to 35 MonthsPrevention of influenza infection in children aged 6 to 35 monthsMedDRA version: 17.0Level: LLTClassification code 10022001Term: Influenza (epidemic)System Organ Class: 100000004862EUCTR2013-001231-51-GRSanofi Pasteur9,000
进行中（未招募）
1 期
Efficacy and Immunogenicity Study of Quadrivalent Influenza Vaccine Administered via the Intramuscular Route in Healthy Children Aged 6 to 35 MonthsPrevention of influenza infection in children aged 6 to 35 monthsMedDRA version: 16.1Level: LLTClassification code 10022001Term: Influenza (epidemic)System Organ Class: 100000004862EUCTR2013-001231-51-ITSanofi Pasteur9,000
进行中（未招募）
1 期
Efficacy and Immunogenicity Study of Quadrivalent Influenza Vaccine Administered via the Intramuscular Route in Healthy Children Aged 6 to 35 MonthsPrevention of influenza infection in children aged 6 to 35 monthsMedDRA version: 18.1Level: LLTClassification code 10022001Term: Influenza (epidemic)System Organ Class: 100000004862EUCTR2013-001231-51-ROSanofi Pasteur5,805